RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 95 filers reported holding RELAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267,497 | -33.0% | 31,807 | 0.0% | 0.45% | +70.8% |
| Q2 2023 | $399,496 | -23.7% | 31,807 | 0.0% | 0.26% | -29.0% |
| Q1 2023 | $523,861 | +10.2% | 31,807 | 0.0% | 0.37% | -77.6% |
| Q4 2022 | $475,197 | -33.3% | 31,807 | 0.0% | 1.66% | -29.1% |
| Q3 2022 | $712,000 | +33.6% | 31,807 | 0.0% | 2.34% | +79.3% |
| Q2 2022 | $533,000 | -30.0% | 31,807 | +25.1% | 1.31% | -0.5% |
| Q1 2022 | $761,000 | -2.6% | 25,425 | 0.0% | 1.31% | +48.4% |
| Q4 2021 | $781,000 | +14.0% | 25,425 | +17.0% | 0.88% | +23.8% |
| Q3 2021 | $685,000 | -13.8% | 21,723 | 0.0% | 0.72% | -21.2% |
| Q2 2021 | $795,000 | +15.2% | 21,723 | +8.9% | 0.91% | -1.1% |
| Q1 2021 | $690,000 | +101.2% | 19,952 | +141.8% | 0.92% | +94.3% |
| Q4 2020 | $343,000 | -2.3% | 8,250 | 0.0% | 0.47% | -29.1% |
| Q3 2020 | $351,000 | – | 8,250 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 4,068,574 | $68,149,000 | 5.76% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $467,408,000 | 3.71% |
| BVF INC/IL | 4,384,805 | $73,445,000 | 3.55% |
| Boxer Capital, LLC | 2,669,132 | $44,708,000 | 2.83% |
| Nextech Invest Ltd. | 475,485 | $7,964,000 | 2.69% |
| EcoR1 Capital, LLC | 3,723,541 | $62,369,000 | 2.15% |
| HARBOURVEST PARTNERS LLC | 296,402 | $4,965,000 | 1.63% |
| Integral Health Asset Management, LLC | 436,262 | $7,307,000 | 1.50% |
| Alphabet Inc. | 1,568,753 | $26,277,000 | 1.43% |
| Fernwood Investment Management, LLC | 185,063 | $3,100,000 | 1.34% |